找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatocellular Carcinoma; Cellular and Molecul Rajagopal N. Aravalli,Clifford J. Steer Book 2014 The Author(s) 2014 Hepatocellular carcinom

[復(fù)制鏈接]
查看: 46611|回復(fù): 40
樓主
發(fā)表于 2025-3-21 17:02:49 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Hepatocellular Carcinoma
副標(biāo)題Cellular and Molecul
編輯Rajagopal N. Aravalli,Clifford J. Steer
視頻videohttp://file.papertrans.cn/426/425738/425738.mp4
概述Includes supplementary material:
叢書名稱SpringerBriefs in Cancer Research
圖書封面Titlebook: Hepatocellular Carcinoma; Cellular and Molecul Rajagopal N. Aravalli,Clifford J. Steer Book 2014 The Author(s) 2014 Hepatocellular carcinom
描述.This book provides up-to-date information on the development and progression of hepatocellular carcinoma (HCC) with a review of the cellular and molecular mechanisms involved in the disease process. Recent research in HCC has led to significant progress in our understanding of the cellular processes and molecular mechanisms that occur during multi-stage events that lead to hepatocarcinogenesis. The emergence of micro RNAs and molecular targeted therapies have added a new dimension in our efforts to combat this deadly disease, Chapters include discussion and evaluation of current intervention strategies and therapeutic options and a focus on the novel approaches that are being pursued, such as micro-RNA based therapies and personalized medicine to treat liver cancer. This book will be of interest to basic and clinical researchers, as well as to drug developers..
出版日期Book 2014
關(guān)鍵詞Hepatocellular carcinoma; cirrhosis; gene expression; liver cancer; microRNA; tumor microenvironment
版次1
doihttps://doi.org/10.1007/978-3-319-09414-4
isbn_softcover978-3-319-09413-7
isbn_ebook978-3-319-09414-4Series ISSN 2194-1173 Series E-ISSN 2194-1181
issn_series 2194-1173
copyrightThe Author(s) 2014
The information of publication is updating

書目名稱Hepatocellular Carcinoma影響因子(影響力)




書目名稱Hepatocellular Carcinoma影響因子(影響力)學(xué)科排名




書目名稱Hepatocellular Carcinoma網(wǎng)絡(luò)公開度




書目名稱Hepatocellular Carcinoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Hepatocellular Carcinoma被引頻次




書目名稱Hepatocellular Carcinoma被引頻次學(xué)科排名




書目名稱Hepatocellular Carcinoma年度引用




書目名稱Hepatocellular Carcinoma年度引用學(xué)科排名




書目名稱Hepatocellular Carcinoma讀者反饋




書目名稱Hepatocellular Carcinoma讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:03:13 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:03:29 | 只看該作者
地板
發(fā)表于 2025-3-22 05:10:31 | 只看該作者
Pathophysiology of HCC,s process. Interaction of a variety of cell types in the tumor stroma with extracellular matrix components lead to the acquisition of an abnormal phenotype that promotes tumor formation. It has also been demonstrated that hypoxia enhances progression, and metastasis of HCC. Activation of epithelial-
5#
發(fā)表于 2025-3-22 12:04:54 | 只看該作者
6#
發(fā)表于 2025-3-22 13:44:42 | 只看該作者
7#
發(fā)表于 2025-3-22 18:29:44 | 只看該作者
8#
發(fā)表于 2025-3-22 23:21:19 | 只看該作者
Conclusions,llular processes and pathways. Thus, molecules such as Sorafenib and microRNAs, which can target multiple pathways simultaneously are necessary therapeutic tools for HCC. Lack of good molecular markers, effective early diagnosis, and an ideal animal model are also major hindrances to treat HCC. Ther
9#
發(fā)表于 2025-3-23 01:38:03 | 只看該作者
ion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,
10#
發(fā)表于 2025-3-23 05:46:35 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 17:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
塔城市| 龙陵县| 白玉县| 静海县| 楚雄市| 鄱阳县| 西畴县| 卢氏县| 兰西县| 延川县| 濉溪县| 正阳县| 太和县| 南丹县| 舒兰市| 周口市| 永登县| 景宁| 建湖县| 永福县| 黔西| 枝江市| 九江县| 茶陵县| 申扎县| 石景山区| 当涂县| 孙吴县| 浙江省| 扎鲁特旗| 台前县| 京山县| 临泉县| 河西区| 定州市| 南汇区| 和龙市| 博白县| 谷城县| 抚松县| 简阳市|